FundedIQ
Biotechnology

Acomhal Research: Funding, Investors & Team (Sep 2026)

Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells. The company was co-founded by Dr. Samy Lamouille and Dr. Robert Gourdie in 2017 at the Fralin Biomedical Research Institute at Virginia Tech Carilion.

www.acomhalresearch.com LinkedIn Roanoke, United States 1-10 employees
Total raised
$300k
Rounds
1
Latest
Grant
Jan 2022

Acomhal Research has raised $300k across 1 funding round on record, the most recent a Grant of $300k announced in Jan 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Acomhal Research Company Profile and Key Stats

Total funding raised
$300k
across 1 round on record
Funding rounds on record
1
Latest funding round
Grant
$300k in Jan 2022
Employees
1-10
reported band
Headquarters
Roanoke, United States

Latest funding round on record: Jan 2022.

Acomhal Research Funding Rounds

Date
Round
Amount
Grant
$300k

Acomhal Research Founders and Leadership Team

Name
Role
Contact
Samy Lamouille
CEO
Locked

Contact details for the Acomhal Research team: 1 of 1 has an email address on file.

Start 14-day free trial →

Acomhal Research Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
1,065

Acomhal Research's latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Acomhal Research in Biotechnology and Roanoke

Companies Similar to Acomhal Research

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Acomhal Research Funding FAQs

What does Acomhal Research do?

Acomhal Research is a biotech startup company that develops novel treatments targeting cancer cells. The company was co-founded by Dr. Samy Lamouille and Dr. Robert Gourdie in 2017 at the Fralin Biomedical Research Institute at Virginia Tech Carilion.

How much funding has Acomhal Research raised?

Acomhal Research has raised $300k across 1 round on record. The most recent is a Grant of $300k announced in Jan 2022.

When did Acomhal Research last raise funding?

Acomhal Research's most recent funding round on record is a Grant of $300k, announced in Jan 2022.

Who is the CEO of Acomhal Research?

Samy Lamouille is listed as CEO at Acomhal Research.

Where is Acomhal Research headquartered?

Acomhal Research is based in Roanoke, Virginia, United States.

How many employees does Acomhal Research have?

Acomhal Research is in the 1-10 employee band.

How does Acomhal Research's funding compare to other Biotechnology startups?

Acomhal Research's latest round of $300k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Acomhal Research Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acomhal Research is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.